OROPHARYNX SQUAMOUS CELL CARCINOMA

This study tested whether adding the immunotherapy drug nivolumab to standard radiation and chemotherapy could help people with high-risk HPV-related throat cancer live longer without their cancer growing. Twenty-six participants received the combination treatment. The goal was t…

This early-phase trial tested a combination of two drugs (IRX-2 regimen and durvalumab) in 19 patients with advanced head and neck cancer that could not be cured with standard treatments. The main goals were to check safety and see if the drugs could boost the immune response ins…

This study tested a new therapy for head and neck cancer survivors who have long-term swallowing problems. 88 adults who finished cancer treatment at least 3 months ago learned to swallow at the right time during breathing. The goal was to make swallowing safer and reduce food or…

This study looked at 132 people with oral or throat cancer who needed part of their jaw removed and rebuilt using a bone from their leg. Half had standard surgery, and half had 3D virtual planning before the operation. The main goal was to see if virtual planning improved quality…

This study looked at how well people could swallow and speak after surgery for mouth or throat cancer, when a collagen patch was used to help rebuild the area. Thirty-three patients filled out questionnaires about their swallowing and voice before surgery, and again at 1 month an…